SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001654954-24-010915
Filing Date
2024-08-19
Accepted
2024-08-19 17:18:23
Documents
99
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A fsd_6ka.htm   iXBRL 6-K/A 177220
2 FINANCIAL STATEMENTS fsd_ex991.htm   iXBRL EX-99.1 1009664
3 MDA fsd_ex992.htm EX-99.2 344304
4 CEO CERTIFICATE fsd_ex993.htm EX-99.3 2013
5 CFO CERTIFICATE fsd_ex994.htm EX-99.4 1559
11 fsd_ex994img1.jpg GRAPHIC 221736
12 fsd_ex994img2.jpg GRAPHIC 47889
13 fsd_ex993img2.jpg GRAPHIC 48371
14 fsd_ex993img1.jpg GRAPHIC 221685
  Complete submission text file 0001654954-24-010915.txt   7614905

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fsd-20240630.xsd EX-101.SCH 105331
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE fsd-20240630_lab.xml EX-101.LAB 388163
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fsd-20240630_cal.xml EX-101.CAL 60471
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fsd-20240630_pre.xml EX-101.PRE 331322
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fsd-20240630_def.xml EX-101.DEF 219783
102 EXTRACTED XBRL INSTANCE DOCUMENT fsd_6ka_htm.xml XML 1360903
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39152 | Film No.: 241221677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)